Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 3;17(8):2626-2629.
doi: 10.1080/21645515.2021.1885282. Epub 2021 Mar 26.

Pembrolizumab for choroidal metastases from non-small cell lung cancer: a case report and literature review

Xinsheng Li  1 , Ya Liang  1 , Jingfan Wang  1 , Zizhong Hu  1 , Zhi-Lan Yuan  1 , Ping Xie  1
Affiliations
Review

Pembrolizumab for choroidal metastases from non-small cell lung cancer: a case report and literature review

Xinsheng Li et al. Hum Vaccin Immunother. .

Abstract

We described a 65-year-old male with choroidal metastases (CM) from non-small cell lung cancer (NSCLC). Pembrolizumab (Keytruda) combined with pemetrexed and capecitabine achieved excellent outcomes. After two cycles of pembrolizumab and chemotherapy, blurred vision and left eye pain were significantly relieved. Imaging and ophthalmologic examinations demonstrated complete resolution of the CM, as well as reduction of pulmonary shadow. CM from NSCLC shows complete and durable response to pembrolizumab and chemotherapy. We suggesting that immunotherapy combined with chemotherapy is a promising treatment for CM from NSCLC.

Keywords: Immunotherapy; choroidal metastases; non-small cell lung cancer; pembrolizumab.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Ocular and medical imaging examination of pre-immunotherapy. (a) Ocular ultrasonography. (b) The early stage of FFA. (c) The late stage of FFA. (d) ICGA of fundus. (e) Chest high-resolution CT. (f) MRI of brain
Figure 2.
Figure 2.
Ocular and medical imaging examination of post-immunotherapy. (a) Ocular ultrasonography. (b) The early stage of FFA. (c) The late stage of FFA. (d) Chest high-resolution CT
See this image and copyright information in PMC

References

    1. Arepalli S, Kaliki S, Shields CL.. Choroidal metastases: origin, features, and therapy. Indian J Ophthalmol. 2015;63:122–27. doi: 10.4103/0301-4738.154380. - DOI - PMC - PubMed
    1. Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104:1265–76. doi: 10.1016/S0161-6420(97)30148-1. - DOI - PubMed
    1. Gozzi E, Angelini F, Rossi L, Leoni V, Trenta P, Cimino G, Tomao S. Alectinib in the treatment of ocular metastases of ALK rearranged non small cell lung cancer: description of 2 case reports. Medicine (Baltimore). 2020;99:e21004. doi: 10.1097/MD.0000000000021004. - DOI - PMC - PubMed
    1. Mathis T, Jardel P, Loria O, Delaunay B, Nguyen AM, Lanza F, et al. New concepts in the diagnosis and management of choroidal metastases. Prog Retin Eye Res. 2019;68:144–76. - PubMed
    1. Raedler LA. Keytruda (Pembrolizumab): first PD-1 inhibitor approved for previously treated unresectable or metastatic melanoma. Am Health Drug Benefits. 2015;8:96–100. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources